Comment

. 2019 Jun;21(6):835-837.

doi: 10.1111/jch.13519. Epub 2019 Mar 15.

Insomnia and hypertension: A misty landscape

Konstantinos Stavropoulos^{1

2}, Konstantinos P Imprialos¹, Michael Doumas^{1

3}, Asterios Karagiannis¹, Vasilios Papademetriou^{2

4}

Affiliations

¹ Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
² Veterans Affairs Medical Center, Georgetown University, Washington, District of Columbia.
³ Veterans Affairs Medical Center, George Washington University, Washington, District of Columbia.
⁴ Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.

PMID: 30874341
PMCID: PMC8030291
DOI: 10.1111/jch.13519

Comment

Insomnia and hypertension: A misty landscape

Konstantinos Stavropoulos et al. J Clin Hypertens (Greenwich). 2019 Jun.

. 2019 Jun;21(6):835-837.

doi: 10.1111/jch.13519. Epub 2019 Mar 15.

Authors

Konstantinos Stavropoulos^{1

2}, Konstantinos P Imprialos¹, Michael Doumas^{1

3}, Asterios Karagiannis¹, Vasilios Papademetriou^{2

4}

Affiliations

¹ Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
² Veterans Affairs Medical Center, Georgetown University, Washington, District of Columbia.
³ Veterans Affairs Medical Center, George Washington University, Washington, District of Columbia.
⁴ Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.

PMID: 30874341
PMCID: PMC8030291
DOI: 10.1111/jch.13519

No abstract available

Keywords: ambulatory blood pressure monitoring; blood pressure; hypertension; insomnia; suvorexant.

PubMed Disclaimer

Conflict of interest statement

The authors report no specific funding in relation to this research and no conflicts of interest to disclose.

Comment on

Effect of suvorexant on nighttime blood pressure in hypertensive patients with insomnia: The SUPER-1 study.
Kario K, Yamasaki K, Yagi K, Tsukamoto M, Yamazaki S, Okawara Y, Tomitani N, Kanegae H. Kario K, et al. J Clin Hypertens (Greenwich). 2019 Jul;21(7):896-903. doi: 10.1111/jch.13505. Epub 2019 Mar 15. J Clin Hypertens (Greenwich). 2019. PMID: 30874378 Free PMC article. Clinical Trial.

References

1. Riemann D, Spiegelhalder K, Feige B, et al. The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med. Rev. 2010;14:19‐31. - PubMed
1. Osborne R. First‐in‐class insomnia drug on the brink of approval nod. Nat Rev Drug Discov. 2013;12:492‐493. - PubMed
1. Crow JM. Insomnia: chasing the dream. Nature. 2013;497:S16‐S18. - PubMed
1. Coleman PJ, Gotter AL, Herring WJ, Winrow CJ, Renger JJ. The discovery of suvorexant, the first orexin receptor drug for insomnia. Annu Rev Pharmacol Toxicol. 2017;57:509‐533. - PubMed
1. St‐Onge MP, Grandner MA, Brown D, et al. Sleep duration and quality: impact on lifestyle behaviors and cardiometabolic health: a scientific statement from the American heart association. Circulation. 2016;134:e367‐e386. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Insomnia and hypertension: A misty landscape

Affiliations

Insomnia and hypertension: A misty landscape

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Conflict of interest statement

Comment on

Similar articles

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Medical